Latest Anti-diabetic medication Stories
The Lack of Reimbursement for DPP-IV Inhibitors and GLP-1 Analogues Hinders Their Uptake Among Chinese Patients, According to Findings from Decision Resources Group BURLINGTON, Mass., Dec.
ResearchMoz.us include new market research report "Global Diabetes Market 2014 Edition" to its huge collection of research reports.Browse latest reports from ResearchMoz at:
The Firm is evaluating Byetta lawsuits and other product liability claims on behalf of individuals who allegedly developed pancreatic cancer, pancreatitis or thyroid cancer after taking incretin
Expresses Continued Confidence in ACTOS DEERFIELD, Ill. and OSAKA, Japan, Nov.
- Intarcia grants Servier exclusive rights to ITCA 650 in ex-U.S./Japan territories; Intarcia retains full control of ITCA 650 in the United States and plans another partner in Japan.
Once-weekly treatment for adults with type 2 diabetes comes in a pen with a no-see, no-handle needle INDIANAPOLIS, Nov.
Culinary Expert Visits Los Angeles on November 9 to Help Educate At-Risk Population About Ingredients for Successful Blood Sugar Management WHITEHOUSE STATION, N.J., Nov.
This November, Medicationdiscountcard.com (MDC) will highlight its discount cards for diabetic medications.
New evidence helps guide first line diabetes therapy selection given limited comparative effectiveness data WOONSOCKET, R.I., Oct.
Expresses Continued Confidence in ACTOS DEERFIELD, Ill. and OSAKA, Japan, Oct.
- To play, gamble.
- To impose upon; delude; trick; humbug; also, to joke; chaff.
- A deceitful game or trick; trickery; humbug; nonsense.